Targeting post-mitochondrial effectors of apoptosis for neuroprotection Review uri icon


MeSH Major

  • Apoptosis
  • Mitochondria
  • Mitochondrial Membranes
  • Neuroprotective Agents


  • Mitochondrial membrane permeabilization (MMP) is commonly regarded as the "point-of-no-return" in the cascade of events that delineate the intrinsic pathway of apoptosis. MMP leads to the functional impairment of mitochondria and to the release into the cytosol of toxic proteins that are normally confined within the mitochondrial intermembrane space. These include direct activators of caspases and caspase-independent effectors of the cell death program. MMP has been implicated in a plethora of pathophysiological settings. In particular, MMP contributes to both the immediate and delayed phases of cell loss that follow acute neuronal injury by ischemia/reperfusion or trauma. Although preventing MMP a priori would be the most desirable therapeutic choice, prophylactic interventions are rarely (if ever) achievable in the treatment of stroke and trauma patients. Conversely, interventions that block the post-mitochondrial phase of apoptosis (if administered within the first few hours after the accident) hold great promises for the development of novel neuroprotective strategies. In animal models of acute neuronal injury, the inhibition of caspases, apoptosis-inducing factor (AIF) and other apoptotic effectors can confer significant neuroprotection. Our review recapitulates the results of these studies and proposes novel strategies of inhibiting post-mitochondrial apoptosis in neurons.

publication date

  • May 2009



  • Review



  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.bbabio.2008.09.006

PubMed ID

  • 18848916

Additional Document Info

start page

  • 402

end page

  • 13


  • 1787


  • 5